Coloplast A/S (CLPBF)
61.62
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Coloplast Gross Profit Margin (Quarterly) : 66.73% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.73% |
| March 31, 2026 | 42.95% |
| December 31, 2025 | 67.23% |
| September 30, 2025 | 68.42% |
| June 30, 2025 | 67.62% |
| March 31, 2025 | 68.23% |
| December 31, 2024 | 67.61% |
| September 30, 2024 | 66.73% |
| June 30, 2024 | 67.51% |
| March 31, 2024 | 67.98% |
| December 31, 2023 | 68.18% |
| September 30, 2023 | 66.37% |
| June 30, 2023 | 65.86% |
| March 31, 2023 | 66.44% |
| December 31, 2022 | 67.91% |
| September 30, 2022 | 68.82% |
| June 30, 2022 | 69.21% |
| March 31, 2022 | 68.72% |
| December 31, 2021 | 68.29% |
| September 30, 2021 | 69.04% |
| June 30, 2021 | 68.98% |
| March 31, 2021 | 68.40% |
| December 31, 2020 | 67.67% |
| September 30, 2020 | 68.85% |
| June 30, 2020 | 67.21% |
| Date | Value |
|---|---|
| March 31, 2020 | 67.80% |
| December 31, 2019 | 68.17% |
| September 30, 2019 | 68.64% |
| June 30, 2019 | 67.91% |
| March 31, 2019 | 67.19% |
| December 31, 2018 | 67.18% |
| September 30, 2018 | 68.85% |
| June 30, 2018 | 66.51% |
| March 31, 2018 | 66.79% |
| December 31, 2017 | 67.41% |
| September 30, 2017 | 68.37% |
| June 30, 2017 | 67.87% |
| March 31, 2017 | 67.89% |
| December 31, 2016 | 68.71% |
| September 30, 2016 | 68.49% |
| June 30, 2016 | 68.15% |
| March 31, 2016 | 68.14% |
| December 31, 2015 | 68.54% |
| September 30, 2015 | 69.40% |
| June 30, 2015 | 67.68% |
| March 31, 2015 | 68.49% |
| December 31, 2014 | 68.56% |
| September 30, 2014 | 69.51% |
| June 30, 2014 | 68.35% |
| March 31, 2014 | 68.58% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Ambu A/S | 59.45% |
| Novo Nordisk A/S | 78.21% |
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.00% |
| Return on Assets | 5.78% |
| Return on Invested Capital | 7.16% |
| Profit Margin (Quarterly) | 19.88% |
| Operating Margin (Quarterly) | 25.89% |
| Return on Net Operating Assets | 6.08% |